American Vanguard (AVD) investor relations material

Executive summary

• Adjusted EBITDA rose to $8.2 million from $1.8 million year-over-year, a 350%+ increase, driven by operational improvements and cost controls.

• Gross profit margin improved by 300 basis points to 29% from 15% year-over-year, reflecting manufacturing optimization and lower costs.

• Net sales for Q3 2025 were $119 million, up 1% year-over-year, with domestic sales up 8% and international sales down 6%.

• Net loss narrowed to $12.4 million from $25.7 million in the prior year quarter; EPS improved to $(0.43) from $(0.91).

• Transformation activities are now managed internally, with related spend reduced by nearly $7 million year-over-year.

Financial highlights

• Q3 2025 net sales were $119 million (+1% YoY); gross profit was $34.2 million, nearly doubling from $17.3 million in Q3 2024.

• Gross profit margin increased to 29% from 15% year-over-year; adjusted EBITDA margin improved to 7% from 1%.

• Operating expenses decreased by 11% for the quarter and 14% year-to-date, with research and product development costs down $5.5 million.

• Net debt reduced by $2 million year-over-year; inventory reduced by $47 million.

• Q3 net loss was $12.4 million; nine months net loss was $21.7 million, improved from $35.9 million loss in 2024.

Outlook and guidance

• Full-year 2025 adjusted EBITDA guidance maintained at $40 million-$44 million; net sales forecast at $520 million-$535 million.

• Management expects Q4 to be the strongest quarter, with material free cash flow anticipated for debt reduction.

• CapEx expected at $5 million-$6 million for 2025, with most free cash flow to be used for debt paydown.

• Company aims to reduce leverage ratio below 3x by next year, supporting refinancing efforts.

• Further gross profit margin improvement is expected due to ongoing efficiency initiatives.